(Q35173073)

English

Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family (English)

1 reference

Europe PubMed Central

6 August 2017

1 reference

based on heuristic

inferred from title

author name string

Bellmunt J

1

1 reference

Europe PubMed Central

6 August 2017

Hussain M

2

1 reference

Europe PubMed Central

6 August 2017

Dinney CP

3

1 reference

Europe PubMed Central

6 August 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

6 August 2017

Critical Reviews in Oncology Hematology

1 reference

Europe PubMed Central

6 August 2017

46 Suppl

1 reference

Europe PubMed Central

6 August 2017

S85-104

1 reference

Europe PubMed Central

6 August 2017

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: an active and tolerable outpatient regimen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Look at a tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Specificity within the EGF family/ErbB receptor family signaling network

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Signal transduction through MAP kinase cascades

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Heregulin regulation of Akt/protein kinase B in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oncogenic kinase signalling

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

New drugs and new approaches in metastatic bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The epidermal growth factor receptor in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential expression of epidermal growth factor receptor in human head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced growth rate accompanied by aberrant epidermal growth factor signaling in drug resistant human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The EGF receptor family as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

ZD1839 ('Iressa') as an anticancer agent

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

EGFR and cancer prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The Willet F. Whitmore, Jr., Lectureship: blockade of epidermal growth factor receptors as anticancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor receptor and bladder cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Growth factors and bladder cancer: clinical implications of the interactions between growth factors and their urothelial receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of angiogenesis during the transition from hyperplasia to neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiogenic Activity as a Marker of Neoplastic and Preneoplastic Lesions of the Human Bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of scatter factor in human bladder carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Transforming growth factors-beta 1 and beta 2 in serum and urine from patients with bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of the epidermal growth factor receptor by basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cross talk among tyrosine kinase receptors in PC12 cells: desensitization of mitogenic epidermal growth factor receptors by the neurotrophic factors, nerve growth factor and basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical prostatectomy after definitive radiation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Raf-1 protein kinase is an integral component of the oncogenic signal cascade shared by epidermal growth factor and platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erbB-2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor stimulates the synthesis of cell-attachment proteins in the human breast cancer cell line PMC42.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of type IV collagenase regulation by hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplification of a novel v-erbB-related gene in a human mammary carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

C-erbB-2 in bladder cancer: molecular biology, correlation with epidermal growth factor receptors and prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of Immunohistochemically Demonstrated c-erb B-2 Oncoprotein Expression as a Prognostic Factor in Transitional Cell Carcinoma of the Urinary Bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erbB-2 oncoprotein expression in primary human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA, RNA and immunohistochemical characterization of the HER-2/neu oncogene in transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of epidermal growth factor receptors in bladder tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Biologic and clinical significance of HER-2/neu (cerbB-2) in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')2 bispecific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical experience with CD64-directed immunotherapy. An overview

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Humanization of an anti-p185HER2 antibody for human cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Tyrosine kinase inhibition: an approach to drug development

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A specific inhibitor of the epidermal growth factor receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinase inhibitors in cancer therapy: a look ahead

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel approaches to the treatment of non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Combinatorial chemoprevention of intestinal neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900067-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1040-8428(03)00067-2

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35173073&oldid=1572790071"